Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Capital Expenditures (2016 - 2026)

United Therapeutics' Capital Expenditures history spans 17 years, with the latest figure at $172.9 million for Q4 2025.

  • On a quarterly basis, Capital Expenditures rose 99.42% to $172.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $520.5 million, a 111.16% increase, with the full-year FY2025 number at $520.5 million, up 111.16% from a year prior.
  • Capital Expenditures hit $172.9 million in Q4 2025 for United Therapeutics, down from $210.5 million in the prior quarter.
  • Over the last five years, Capital Expenditures for UTHR hit a ceiling of $210.5 million in Q3 2025 and a floor of -$84.8 million in Q4 2022.
  • Historically, Capital Expenditures has averaged $50.8 million across 5 years, with a median of $39.8 million in 2023.
  • Biggest five-year swings in Capital Expenditures: soared 457.38% in 2021 and later crashed 174.42% in 2023.
  • Tracing UTHR's Capital Expenditures over 5 years: stood at -$46.5 million in 2021, then crashed by 82.37% to -$84.8 million in 2022, then soared by 330.66% to $195.6 million in 2023, then crashed by 55.67% to $86.7 million in 2024, then surged by 99.42% to $172.9 million in 2025.
  • Business Quant data shows Capital Expenditures for UTHR at $172.9 million in Q4 2025, $210.5 million in Q3 2025, and $62.2 million in Q2 2025.